Literature DB >> 33786165

The correlation between the gleason score of the biopsy and that of the prostatectomy patch.

W Bai1,2, Y Fadil1,2, O Idrissi1,2, M Dakir1,2, A Debbagh1,2, R Abouteib1,2.   

Abstract

Since the advent of massive dosage of prostate specific antigen (PSA), prostate cancer has become a major public health problem. It is currently the most common cancer and the second leading cause of cancer death in men (after lung cancer). More than 670,000 new cases are diagnosed annually worldwide. This is a retrospective study including all patients treated for prostate cancer by radical prostatectomy at the Ibn Rochde University Hospital in Casablanca between January 2017 and December 2020, i.e. a period of 4 years. At the end of our study, we identified 18 cases of radical prostatectomy.
© 2021 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.

Entities:  

Year:  2021        PMID: 33786165      PMCID: PMC7990678          DOI: 10.1016/j.amsu.2021.02.015

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


  17 in total

1.  [Correlation between Gleason score of prostatic biopsies and the one of the radical prostatectomy specimen].

Authors:  J Prost; N Gros; C Bastide; F Bladou; G Serment; D Rossi
Journal:  Prog Urol       Date:  2001-02       Impact factor: 0.915

2.  Comparison of Gleason grade and score between preoperative biopsy and prostatectomy specimens in prostate cancer.

Authors:  Susumu Tomioka; Hiroomi Nakatsu; Noriyuki Suzuki; Shino Murakami; Osamu Matsuzaki; Jun Shimazaki
Journal:  Int J Urol       Date:  2006-05       Impact factor: 3.369

3.  Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.

Authors:  Felix K-H Chun; Alberto Briganti; Shahrokh F Shariat; Markus Graefen; Francesco Montorsi; Andreas Erbersdobler; Thomas Steuber; Andrea Salonia; Eike Currlin; Vincenzo Scattoni; Martin G Friedrich; Thorsten Schlomm; Alexander Haese; Uwe Michl; Renzo Colombo; Hans Heinzer; Luc Valiquette; Patrizio Rigatti; Claus G Roehrborn; Hartwig Huland; Pierre I Karakiewicz
Journal:  BJU Int       Date:  2006-08       Impact factor: 5.588

4.  Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time.

Authors:  Simon R J Bott; A Alex Freeman; Sally Stenning; Jonathan Cohen; M Constance Parkinson
Journal:  BJU Int       Date:  2005-01       Impact factor: 5.588

5.  Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies.

Authors:  D G Bostwick
Journal:  Am J Surg Pathol       Date:  1994-08       Impact factor: 6.394

6.  Prostate gland biopsies and prostatectomies: an Ontario community hospital experience.

Authors:  Ken J Newell; John F Amrhein; Rashmikant J Desai; Paul F Middlebrook; Todd M Webster; Barry W Sawka; Brian F Rudrick
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

7.  Pathological correlation between needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer.

Authors:  Muhammad A Bulbul; Yaser El-Hout; Maurice Haddad; Ayman Tawil; Ali Houjaij; Nizar Bou Diab; Oussama Darwish
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

8.  Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer.

Authors:  Stephen J Freedland; Christopher J Kane; Christopher L Amling; William J Aronson; Joseph C Presti; Martha K Terris
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

9.  The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.

Authors:  Stephen A Boorjian; R Jeffrey Karnes; Paul L Crispen; Laureano J Rangel; Eric J Bergstralh; Thomas J Sebo; Michael L Blute
Journal:  J Urol       Date:  2008-11-13       Impact factor: 7.450

10.  Role of prostate biopsy schemes in accurate prediction of Gleason scores.

Authors:  Badar M Mian; David J Lehr; Courtenay K Moore; Hugh A G Fisher; Ronald P Kaufman; Jeffery S Ross; Timothy A Jennings; Tipu Nazeer
Journal:  Urology       Date:  2006-02       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.